Nicholson Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
2,298
-9
-0.4% -$9.2K 1.62% 9
2026
Q1
$2.12M Sell
2,307
-112
-5% -$114K 1.23% 22
2025
Q4
$2.6M Sell
2,419
-163
-6% -$156K 1.53% 7
2025
Q3
$1.97M Buy
2,582
+988
+62% +$735K 1.15% 24
2025
Q2
$1.24M Buy
1,594
+543
+52% +$422K 0.77% 73
2025
Q1
$868K Buy
1,051
+631
+150% +$525K 0.57% 78
2024
Q4
$324K Hold
420
0.22% 93
2024
Q3
$372K Buy
+420
New +$378K 0.31% 88

Other funds holding LLY

Nicholson Wealth Management Group's LLY Position: Q2 2026 in Review

Nicholson Wealth Management Group reduced its Eli Lilly (LLY) stake by 0.39% in Q2 2026, selling an estimated $9.2K and leaving 2,298 shares worth $2.76M. The position accounts for 1.62% of the portfolio, ranked #9.

Nicholson Wealth Management Group first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nicholson Wealth Management Group held 2,298 shares of Eli Lilly worth $2.76M as of Q2 2026.
  • Nicholson Wealth Management Group sold 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 1.62% of Nicholson Wealth Management Group's portfolio in Q2 2026, its #9 holding.
  • Nicholson Wealth Management Group first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nicholson Wealth Management Group's 13F filing for Q2 2026, filed 29 Jul 2026.